Neurotech completes recruitment in Phase 2/3 autism spectrum disorder trial
Special Report: Clinical-stage biopharmaceutical development company Neurotech International is on track to deliver results for its Phase 2/3 NTIASD2 clinical trial for children with autism spectrum [more…]
MTM picks up niobium-REE project in WA’s West Arunta region
Special Report: MTM Critical Metals is acquiring Flash Metals – and three key exploration licenses prospective for niobium and rare earth elements (REE) in the [more…]
ASX Health Stocks: dorsaVi up 27pc on US deals, Starpharma reports positive outcome on Phase 2 trial
Starpharma reports positive outcome on Phase 2 trial Starpharma Holdings (ASX:SPL) announced positive final results from the completed Phase 2 clinical program of DEP docetaxel. [more…]
Miramar spots large-scale magnetite iron opportunities at Whaleshark
Special Report: A review of historical drill data has revealed some potentially significant magnetite iron opportunities at Miramar Resources’ Whaleshark project in WA. Drilling conducted [more…]
‘Strong and competitive economics’: Lake’s DFS for Kachi leads the charge to bring lithium to market in Argentina
Special Report: Lake’s Phase 1 Definitive Feasibility Study (DFS) for the Kachi lithium brine project in Argentina paints a picture of a Tier One project, [more…]
Ground Breakers: Azure lithium takeover alive again as SQM and Hancock join forces
King (or Queen) maker Mark Creasy has backed a $3.70 per share offer for lithium hopeful Azure Minerals (ASX:AZS) from Chilean giant and Gina Rinehart’s [more…]
Bitcoin’s ecosystem will power the next bull market, helping deliver a US$100k BTC, says Bitget
Special Report: Bitcoin’s growing ecosystem and capability as a layer 1 network is the narrative to watch in 2024, reports Bitget – one of the [more…]
Top 10 at 10: All eyes are on Azure, SQM, and Gina
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
‘World first’: AdAlta’s i-body platform a breakthrough for malaria treatment
Special Report: AdAlta, in collaboration with La Trobe University, has made a world-first breakthrough using its i-body® platform which could provide potential new treatments for malaria. [more…]
Thrive investment is making popular healthy snack maker Daily Food ‘a player on a bigger scale’
Thrive Tribe (ASX:1TT) invests in companies in the health and wellness space 1TT’s 51% stake in healthy snack maker Daily Food underpins ambitious growth strategy [more…]
